Key facts
- It has raised $14.3M; the latest was Later Stage VC ($8.3M) in Jan 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Element Eight
- ·The full record, as it builds
Funding rounds
No funding rounds for Element Eight are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Element Eight
Manufacturer of oxygen-infusing skincare products intended to promote cell regeneration and reduce the appearance of aging. The company's products are scientifically proven benefits of oxygen for the skin including speeding repair and recovery, boosting the skin metabolism, reviving regeneration, increasing collagen, lessening fine lines and wrinkles, enabling customers to have skincare products that are effective than traditional products.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Sherman Oaks, CA, United States
- Founded
- 2017
- Employees
- 5
- Website
- elementeight.com/
- Ownership
- Privately Held (backing)
Element Eight doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Element Eight shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Element Eight in its N-PORT filings yet. We sweep new filings monthly.